by Media Coverage | Oct 29, 2021 | Blog
Assay Detects Precancerous Colorectal Cancer Lesions & Mutations FollowFollowFollow Written by Chris Wolskiat Clinical Lab Products Read the article on Clinical Lab Products Success! Email Subscribe Early Cancer Detection Will Save More Lives Nov 23, 2021 |...
by Wei Liu, PhD | Nov 23, 2021 | Blog
Early Cancer Detection Will Save More Lives FollowFollowFollow Cancer deaths due to failure of early detection According to the American Cancer Society researchers, it is estimated that there will be more than 600,000 people die of cancer, and 1.9 million new cancer...
by Media Coverage | May 13, 2021 | Blog
DiaCarta Positioning Liquid Biopsy Assay to Gauge Chemotherapy Response in Multiple Cancers FollowFollowFollow Written by John Gilmore at genomeweb Read the article on genomeweb Download the article NEW YORK – On the heels of newly published data, Diacarta plans to...
by Wei Liu, Ph.D. | Aug 22, 2018 | Blog
Month: August 2018 FollowFollowFollow Colorectal cancer (CRC), including colon and rectum cancer, is the third most common cancer in the world and the third in the US as well. American Cancer Society (ACS) estimates that there are 97,220 and 43,030 new cases in 2018...
by Media Coverage | Oct 27, 2017 | Blog
Media Coverage FollowFollowFollow NEW YORK (GenomeWeb) – MDx firm Diacarta shared new data today on the use of its colorectal cancer mutation assay in analyzing blood samples of patients with early-stage colorectal cancer, positioning the kit as a liquid biopsy tool....
by Media Coverage | May 30, 2018 | Blog
Media Coverage FollowFollowFollow “Well-being of individuals around the world,” say Dr. Aiguo Zhang Founder and CEO and Dr. Michael J Powell, CSO of DiaCarta, is one of the collective passions that they both shared that has kept California based DiaCarta up and...
Recent Comments